扶桑薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/12/08 | 1,893 | 1,895 | 1,872 | 1,884 | -11 | -0.6% | 45,700 |
2023/12/07 | 1,905 | 1,905 | 1,895 | 1,895 | -13 | -0.7% | 14,600 |
2023/12/06 | 1,905 | 1,910 | 1,899 | 1,908 | +13 | +0.7% | 28,500 |
2023/12/05 | 1,908 | 1,914 | 1,895 | 1,895 | -14 | -0.7% | 22,800 |
2023/12/04 | 1,909 | 1,913 | 1,900 | 1,909 | -3 | -0.2% | 22,000 |
2023/12/01 | 1,909 | 1,921 | 1,908 | 1,912 | +5 | +0.3% | 30,600 |
2023/11/30 | 1,902 | 1,910 | 1,891 | 1,907 | +4 | +0.2% | 27,100 |
2023/11/29 | 1,912 | 1,914 | 1,903 | 1,903 | -11 | -0.6% | 14,900 |
2023/11/28 | 1,906 | 1,914 | 1,902 | 1,914 | +8 | +0.4% | 26,900 |
2023/11/27 | 1,909 | 1,913 | 1,902 | 1,906 | ±0 | ±0% | 18,700 |
2023/11/24 | 1,899 | 1,906 | 1,895 | 1,906 | +14 | +0.7% | 26,400 |
2023/11/22 | 1,890 | 1,903 | 1,890 | 1,892 | +2 | +0.1% | 12,800 |
2023/11/21 | 1,886 | 1,897 | 1,885 | 1,890 | -3 | -0.2% | 18,400 |
2023/11/20 | 1,901 | 1,909 | 1,892 | 1,893 | -12 | -0.6% | 28,300 |
2023/11/17 | 1,885 | 1,908 | 1,881 | 1,905 | +19 | +1% | 23,900 |
2023/11/16 | 1,900 | 1,901 | 1,885 | 1,886 | -10 | -0.5% | 26,800 |
2023/11/15 | 1,895 | 1,902 | 1,892 | 1,896 | +5 | +0.3% | 24,200 |
2023/11/14 | 1,904 | 1,904 | 1,891 | 1,891 | -13 | -0.7% | 21,900 |
2023/11/13 | 1,897 | 1,916 | 1,889 | 1,904 | +5 | +0.3% | 25,100 |
2023/11/10 | 1,907 | 1,912 | 1,894 | 1,899 | -19 | -1% | 36,900 |
2023/11/09 | 1,909 | 1,924 | 1,903 | 1,918 | +9 | +0.5% | 23,000 |
2023/11/08 | 1,933 | 1,933 | 1,891 | 1,909 | -9 | -0.5% | 26,200 |
2023/11/07 | 1,922 | 1,939 | 1,916 | 1,918 | -11 | -0.6% | 16,500 |
2023/11/06 | 1,956 | 1,956 | 1,928 | 1,929 | -13 | -0.7% | 26,200 |
2023/11/02 | 1,940 | 1,942 | 1,921 | 1,942 | +5 | +0.3% | 22,900 |
2023/11/01 | 1,955 | 1,960 | 1,934 | 1,937 | -9 | -0.5% | 35,100 |
2023/10/31 | 1,920 | 1,946 | 1,912 | 1,946 | +24 | +1.2% | 20,800 |
2023/10/30 | 1,953 | 1,953 | 1,919 | 1,922 | -31 | -1.6% | 65,800 |
2023/10/27 | 1,950 | 1,958 | 1,944 | 1,953 | +13 | +0.7% | 21,200 |
2023/10/26 | 1,940 | 1,956 | 1,940 | 1,940 | +5 | +0.3% | 19,900 |
2023/10/25 | 1,949 | 1,950 | 1,934 | 1,935 | -2 | -0.1% | 20,100 |
2023/10/24 | 1,937 | 1,939 | 1,895 | 1,937 | +19 | +1% | 47,000 |
2023/10/23 | 1,933 | 1,943 | 1,918 | 1,918 | -12 | -0.6% | 31,200 |
2023/10/20 | 1,939 | 1,947 | 1,930 | 1,930 | -9 | -0.5% | 21,700 |
2023/10/19 | 1,944 | 1,955 | 1,936 | 1,939 | -9 | -0.5% | 23,200 |
2023/10/18 | 1,952 | 1,956 | 1,940 | 1,948 | -4 | -0.2% | 17,500 |
2023/10/17 | 1,953 | 1,963 | 1,946 | 1,952 | +28 | +1.5% | 21,700 |
2023/10/16 | 1,937 | 1,948 | 1,919 | 1,924 | -13 | -0.7% | 24,700 |
2023/10/13 | 1,960 | 1,960 | 1,929 | 1,937 | -23 | -1.2% | 21,800 |
2023/10/12 | 1,970 | 1,970 | 1,952 | 1,960 | -8 | -0.4% | 15,600 |
2023/10/11 | 1,970 | 1,970 | 1,954 | 1,968 | -2 | -0.1% | 17,000 |
2023/10/10 | 1,956 | 1,974 | 1,952 | 1,970 | +18 | +0.9% | 32,800 |
2023/10/06 | 1,924 | 1,963 | 1,924 | 1,952 | +28 | +1.5% | 29,100 |
2023/10/05 | 1,912 | 1,939 | 1,912 | 1,924 | +12 | +0.6% | 38,400 |
2023/10/04 | 1,922 | 1,937 | 1,906 | 1,912 | -19 | -1% | 67,500 |
2023/10/03 | 1,954 | 1,954 | 1,922 | 1,931 | -29 | -1.5% | 66,700 |
2023/10/02 | 1,972 | 1,981 | 1,954 | 1,960 | -11 | -0.6% | 46,700 |
2023/09/29 | 1,999 | 1,999 | 1,961 | 1,971 | -24 | -1.2% | 76,800 |
2023/09/28 | 1,998 | 2,005 | 1,989 | 1,995 | -31 | -1.5% | 43,300 |
2023/09/27 | 2,003 | 2,028 | 1,998 | 2,026 | +17 | +0.8% | 53,500 |
101~
150
件表示中 / 3452件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
扶桑薬 | 224,500円 | +4.5% | -9.7% | 3.12% | 14.76倍 | 0.53倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
セルソース | 142,200円 | +19.0% | -13.1% | 0.35% | 39.17倍 | 4.58倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
クオリプス | 346,500円 | -15.8% | - | 0.00% | - | 4.46倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
大幸薬品 | 35,600円 | +11.1% | - | 0.00% | 32.48倍 | 2.65倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
オンコリス | 68,700円 | +217.5% | - | 0.00% | - | 9.83倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム